Excyte Biopharma Ltd
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma (NCT07695740) | Excyte Biopharma Ltd | 2026-09-01 |
| Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus (NCT07010835) | Excyte Biopharma Ltd | 2025-08-25 |
| Study of YK012 in Primary Membranous Nephropathy (NCT06982729) | Excyte Biopharma Ltd | 2025-03-08 |
| Study of YK012 in B-cell Acute Lymphoblastic Leukemia (NCT06580301) | Excyte Biopharma Ltd | 2024-09-25 |
| A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma (NCT06574568) | Excyte Biopharma Ltd | 2024-06-14 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012 (NCT06565689) | Excyte Biopharma Ltd | 2023-05-09 |
Track Excyte Biopharma Ltd automatically
Every clearance here is in the API, with alerts when new ones post.